Publications
Publication records provide a traceable view of peer-reviewed scientific activity connected to the relevant entity context.
Clinical evidence
Digital Health Clinical Evidence Intelligence
Move beyond publication counts to understand the relevance, recency and decision value of a company’s clinical evidence.
Why it matters
Context before comparison
Clinical evidence is not a binary attribute. A company may have a large body of historical publications that does not support its current product, target population or claimed outcome. Another may have fewer records but more recent, directly relevant evidence.
HealthTech Alpha connects clinical evidence signals to company and product context. This creates a structured starting point for evidence screening, benchmarking and diligence while preserving the need for expert clinical interpretation.
The record model
What this intelligence connects
Each signal remains linked to the entities and context needed to interpret it.
Clinical trials
Trial activity adds information about study stage, indication, intervention and evidence development.
Product and indication links
Evidence is interpreted against the product, use case and healthcare problem it is expected to support.
Evidence chronology
Dates and historical records help distinguish a growing evidence programme from an ageing stock of research.
Analysis workflow
Screen evidence for relevance before counting volume
Define the claim
Specify the outcome, population, intervention and decision that the evidence must support.
Retrieve the record set
Identify relevant publications, trials and related company or product activity.
Assess fit and recency
Separate directly relevant evidence from adjacent science and examine whether evidence generation is continuing.
Escalate for expert review
Use structured screening to focus clinical review, not to replace appraisal of study quality or bias.
Method and governance
Structured for traceable analysis
Entity matching
Evidence records are associated with the appropriate company and product context where that linkage can be supported.
Clinical taxonomy
Indications, interventions and solution categories provide a consistent basis for comparison.
Time-aware analysis
Evidence stock and the rate of new evidence generation can be examined separately.
Traceable records
Users can review the underlying evidence and apply their own clinical and methodological standards.
Decision use cases
Where teams apply the intelligence
Vendor evaluation
Screen whether claims are supported by evidence relevant to the intended healthcare workflow.
Due diligence
Identify the evidence base and questions that require deeper expert review.
Portfolio benchmarking
Compare evidence activity and recency across a defined company cohort.
Research strategy
Monitor how clinical validation is developing across a market or solution category.
Related analysis
See the evidence applied
Explore Galen Growth research built from the same structured intelligence foundation.
FAQ
Questions about the data
Does HealthTech Alpha score clinical quality?
The platform structures evidence signals for screening and comparison. A final judgement about study quality, bias, applicability or clinical benefit requires expert review of the underlying evidence.
Why separate evidence stock from evidence generation?
A large historical publication base may reflect company age or adjacent research. The rate and relevance of newer evidence can provide a different view of current validation activity.
Can clinical evidence be compared across companies?
Yes, when the cohort and comparison criteria are defined consistently. Differences in product type, indication, study design and maturity must remain visible in the interpretation.
HealthTech Alpha intelligence
Explore the connected data domains
See it in your decision context
Bring us the question, not just the search terms.
We will show how HealthTech Alpha structures the relevant records, comparisons and evidence trail.